Serological differentiation between COVID-19 and SARS infections
Open Access
- 1 January 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in Emerging Microbes & Infections
- Vol. 9 (1), 1497-1505
- https://doi.org/10.1080/22221751.2020.1780951
Abstract
In response to the coronavirus disease 2019 (COVID-19) outbreak, caused by SARS-CoV-2, multiple diagnostic tests are required for acute disease diagnosis, contact tracing, monitoring asymptomatic infection rates and assessing herd immunity. While PCR remains the frontline test of choice in the acute diagnostic setting, serological tests are urgently needed. Unlike PCR tests which are highly specific, cross-reactivity is a major challenge for COVID-19 antibody tests considering there are six other coronaviruses known to infect humans. SARS-CoV is genetically related to SARS-CoV-2 sharing approximately 80% sequence identity and both belong to the species SARS related coronavirus in the genus Betacoronavirus of family Coronaviridae. We developed and compared the performance of four different serological tests to comprehensively assess the cross-reactivity between COVID-19 and SARS patient sera. There is significant cross-reactivity when N protein of either virus is used. The S1 or RBD regions from the spike (S) protein offers better specificity. Amongst the different platforms, capture ELISA performed best. We found that SARS survivors all have significant levels of antibodies remaining in their blood 17 years after infection. Anti-N antibodies waned more than anti-RBD antibodies, and the latter is known to play a more important role in providing protective immunity.Keywords
This publication has 34 references indexed in Scilit:
- Antibody-profiling technologies for studying humoral responses to infectious agentsExpert Review of Vaccines, 2010
- New Algorithms and Methods to Estimate Maximum-Likelihood Phylogenies: Assessing the Performance of PhyML 3.0Systematic Biology, 2010
- Antibody Profiling by Luciferase Immunoprecipitation Systems (LIPS)Journal of Visualized Experiments, 2009
- IgM in microbial infections: Taken for granted?Immunology Letters, 2009
- Human coronavirus NL63, a new respiratory virusFEMS Microbiology Reviews, 2006
- Coronavirus HKU1 and Other Coronavirus Infections in Hong KongJournal of Clinical Microbiology, 2006
- Bats Are Natural Reservoirs of SARS-Like CoronavirusesScience, 2005
- Recombinant Protein-Based Enzyme-Linked Immunosorbent Assay and Immunochromatographic Tests for Detection of Immunoglobulin G Antibodies to Severe Acute Respiratory Syndrome (SARS) Coronavirus in SARS PatientsClinical and Vaccine Immunology, 2004
- Severe Acute Respiratory Syndrome (SARS)Journal of Clinical Virology, 2003
- Serologic Evidence for the Presence in Pteropus Bats of a Paramyxovirus Related to Equine MorbillivirusEmerging Infectious Diseases, 1996